Monday, June 1, 2020

Gilead's Remdesivir Shows Fair Improvement In Moderate COVID-19 Patients

Gilead Sciences Inc on Monday reported that its antiviral drug remdesivir provided a modest benefit in patients with moderate COVID-19 given a five-day course of the treatment, while those who...

from NDTV News - Latest https://ift.tt/36PjXS6
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

PM Modi Launches Rs 5,400 Crore Development Projects In Gujarat

Prime Minister Narendra Modi on Monday dedicated and laid the foundation stone for a slew of development projects collectively valued at ove...